LeMaitre Vascular, Inc. (LMAT) Stock Price

LMATStock

$80.45−15.56%52W

Market Cap$1.84B

P/E32.53x

PEG Ratio2.33

Div yield1.05%

Beta0.48

LMAT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-23.28%

Price vs S&P 500 (4W)-23.89%

PEG Ratio2.33

VGM Score52.71

P/E Ratio (Annual)32.53x

Indicated Dividend Yield (Annual)1.05%

P/CF (Annual)23.12x

Book Value / Share (Quarterly)$18.38

P/TBV (Annual)5.10x

Indicated Dividend (Annual)$1.00

Revenue Growth (3Y)15.57%

Cash Flow / Share (Quarterly)$3.23

Payout Ratio (TTM)31.21%

Price vs S&P 500 (YTD)-13.62%

Gross Margin (TTM)72.90%

Net Profit Margin (TTM)25.02%

EPS (TTM)$2.77

10-Day Avg Trading Volume0.33M

EPS Excl Extra (TTM)$2.77

Revenue Growth (5Y)14.04%

EPS (Annual)$2.52

Dividend / Share (Annual)$0.80

ROI (Annual)10.27%

Gross Margin (Annual)71.53%

Net Profit Margin (5Y Avg)17.78%

Cash / Share (Quarterly)$16.45

P/E Basic Excl Extra (TTM)28.60x

Revenue Growth QoQ (YoY)9.57%

EPS Growth (5Y)19.48%

P/E Normalized (Annual)32.53x

ROA (Last FY)9.38%

Revenue Growth TTM (YoY)11.85%

EBITD / Share (TTM)$3.49

ROE (5Y Avg)11.22%

Operating Margin (TTM)29.46%

Cash Flow / Share (Annual)$3.27

P/B Ratio4.47x

P/B Ratio (Quarterly)5.22x

Net Income / Employee (Annual)$89,400

EV / Revenue (TTM)7.70x

Net Interest Coverage (TTM)17.33x

ROA (TTM)10.58%

EPS Growth QoQ (YoY)15.47%

EV / EBITDA (TTM)24.37x

EPS Incl Extra (Annual)$2.52

Current Ratio (Annual)12.89x

Quick Ratio (Quarterly)13.76x

3-Month Avg Trading Volume0.34M

52-Week Price Return-15.56%

EV / Free Cash Flow (Annual)27.14x

P/E Incl Extra (TTM)28.60x

Revenue / Employee (TTM)$406,200

Tangible BV / Share (Quarterly)$17.05

P/S Ratio (Annual)7.53x

Asset Turnover (Annual)0.41x

52-Week High$118.01

Operating Margin (5Y Avg)22.02%

EPS Excl Extra (Annual)$2.52

CapEx CAGR (5Y)17.88%

Tangible BV CAGR (5Y)25.95%

26-Week Price Return-11.35%

Quick Ratio (Annual)10.81x

13-Week Price Return-14.90%

Total Debt / Equity (Annual)0.43x

Current Ratio (Quarterly)16.31x

Enterprise Value$2.02B

Revenue / Share Growth (5Y)11.52%

Asset Turnover (TTM)0.42x

Book Value / Share Growth (5Y)15.47%

Revenue / Employee (Annual)$386,400

Inventory Turnover (Annual)1.05x

Pretax Margin (Annual)30.12%

Cash / Share (Annual)$15.77

3-Month Return Std Dev59.31%

Gross Margin (5Y Avg)67.27%

Net Income / Employee (TTM)$101,700

EBITDA CAGR (5Y)16.83%

EBITDA Interim CAGR (5Y)11.48%

ROE (Last FY)14.67%

Net Interest Coverage (Annual)18.10x

EPS Basic Excl Extra (Annual)$2.52

P/FCF (TTM)25.44x

Receivables Turnover (TTM)7.27x

EV / Free Cash Flow (TTM)27.37x

Total Debt / Equity (Quarterly)0.40x

EPS Incl Extra (TTM)$2.77

Receivables Turnover (Annual)7.84x

ROI (TTM)11.55%

Dividend Growth Rate (5Y)16.13%

P/S Ratio (TTM)7.16x

Pretax Margin (5Y Avg)23.12%

Revenue / Share (Annual)$10.89

Tangible BV / Share (Annual)$15.83

Forward P/E32.49x

Free OCF CAGR (5Y)18.54%

Price vs S&P 500 (52W)-34.11%

P/E Ratio (TTM)28.60x

EPS Growth TTM (YoY)34.39%

Year-to-Date Return-0.80%

5-Day Price Return0.61%

EPS Normalized (Annual)$2.52

ROA (5Y Avg)8.37%

Net Profit Margin (Annual)23.13%

Month-to-Date Return-20.60%

Cash Flow / Share (TTM)$1.64

EBITD / Share (Annual)$3.21

EPS Growth (3Y)39.48%

Operating Margin (Annual)27.21%

LT Debt / Equity (Annual)0.43x

P/CF (TTM)22.64x

ROI (5Y Avg)9.47%

P/E Excl Extra (TTM)28.60x

LT Debt / Equity (Quarterly)0.40x

EPS Basic Excl Extra (TTM)$2.77

P/TBV (Quarterly)5.63x

Payout Ratio (Annual)31.37%

P/B Ratio (Annual)4.68x

Dividend / Share (TTM)$0.90

Inventory Turnover (TTM)1.02x

Pretax Margin (TTM)32.29%

Book Value / Share (Annual)$17.28

Price vs S&P 500 (13W)-16.86%

Net Margin Growth (5Y)7.15%

Dividend Yield (TTM)1.09%

Beta0.48x

P/FCF (Annual)25.22x

Revenue / Share (TTM)$10.70

ROE (TTM)16.42%

52-Week Low$78.27

vGradeC

gGradeB

mGradeC

vgmGradeC

LMAT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.81	$0.74	-8.26%(-$0.07)
Q1 2026	May 5, 2026	$0.66	$0.68	+3.03%(+$0.02)
Q4 2025	Feb 25, 2026	$0.66	$0.68	+2.41%(+$0.02)
Q3 2025	Nov 6, 2025	$0.56	$0.75	+33.14%(+$0.19)
Q2 2025	Aug 5, 2025	$0.57	$0.60	+6.09%(+$0.03)

LMAT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About LeMaitre Vascular, Inc.

LeMaitre Vascular manufactures and distributes medical devices for treating peripheral vascular disease during open surgery, with primary revenue from lower extremity and carotid product lines. Its portfolio includes angioscopes, balloon catheters, vascular grafts, vessel closure systems, and related surgical devices. The company also processes and cryopreserves human tissues for implantation.